Literature DB >> 19034610

Factors predisposing to HTLV-1 infection in residents of the greater Tokyo area.

Kaoru Uchimaru1, Yukari Nakamura2,3, Arinobu Tojo2, Toshiki Watanabe4, Kazunari Yamaguchi5.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) is the etiological agent for adult T-cell leukemia. The geographic distribution of HTLV-1 carriers is quite uneven in Japan and the greatest prevalence is in southwestern Japan. Because many people move from endemic areas to the greater Tokyo area, the geographic distribution might have changed. Therefore, we investigated the factors predisposing to HTLV-1 infection, including birthplace, for 88 HTLV-1-infected individuals in greater Tokyo who visited our outpatient clinic. Of these, 39.5% were born in endemic areas, which include Kyushu/Okinawa, south Shikoku, Kii, Tohoku, and Hokkaido, whereas 38.3% were born in greater Tokyo and the proportion is presumed to be increasing. Half of the HTLV-1 infected individuals in greater Tokyo came from endemic areas, whereas around half of the remaining half was presumed to be involved in sexual transmission from a spouse from an endemic area. Overall, they constituted approximately 70% of the HTLV-1 carriers in greater Tokyo. These migration effects may increase the prevalence of HTLV-1 in the greater Tokyo area; nationwide surveillance is warranted.

Entities:  

Mesh:

Year:  2008        PMID: 19034610     DOI: 10.1007/s12185-008-0209-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  19 in total

1.  Declining trends of HTLV-I prevalence among blood donors in Kumamoto, Japan.

Authors:  K Yamaguchi; Y Nishimura; Y Kusumoto; Y Imamura; S Tokudome; N Tsuji; K Takatsuki
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992

2.  Deoxycoformycin-containing combination chemotherapy for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study (JCOG9109).

Authors:  Kunihiro Tsukasaki; Kensei Tobinai; Masanori Shimoyama; Mitsuo Kozuru; Naokuni Uike; Yasuaki Yamada; Masao Tomonaga; Koichi Araki; Masaharu Kasai; Kiyoshi Takatsuki; Mitsutoshi Tara; Chikara Mikuni; Tomomitsu Hotta
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

3.  Prevalence of possible adult T-cell leukemia virus-carriers among volunteer blood donors in Japan: a nation-wide study.

Authors:  Y Maeda; M Furukawa; Y Takehara; K Yoshimura; K Miyamoto; T Matsuura; Y Morishima; K Tajima; K Okochi; Y Hinuma
Journal:  Int J Cancer       Date:  1984-06-15       Impact factor: 7.396

4.  Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma.

Authors:  Jun Okamura; Atae Utsunomiya; Ryuji Tanosaki; Naokuni Uike; Shunro Sonoda; Mari Kannagi; Masao Tomonaga; Mine Harada; Nobuhiro Kimura; Masato Masuda; Fumio Kawano; Yuji Yufu; Hiroyoshi Hattori; Hiroshi Kikuchi; Yoshio Saburi
Journal:  Blood       Date:  2005-01-21       Impact factor: 22.113

5.  Oral infection of a common marmoset with human T-cell leukemia virus type-I (HTLV-I) by inoculating fresh human milk of HTLV-I carrier mothers.

Authors:  K Kinoshita; K Yamanouchi; S Ikeda; S Momita; T Amagasaki; H Soda; M Ichimaru; R Moriuchi; S Katamine; T Miyamoto
Journal:  Jpn J Cancer Res       Date:  1985-12

6.  Genetic evidence of transmission of human T cell lymphotropic virus type 1 between spouses.

Authors:  Mutsunori Iga; Akihiko Okayama; Sherri Stuver; Masao Matsuoka; Nancy Mueller; Manabu Aoki; Hiroaki Mitsuya; Nobuyoshi Tachibana; Hirohito Tsubouchi
Journal:  J Infect Dis       Date:  2002-02-05       Impact factor: 5.226

7.  A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.

Authors:  Y Yamada; M Tomonaga; H Fukuda; S Hanada; A Utsunomiya; M Tara; M Sano; S Ikeda; K Takatsuki; M Kozuru; K Araki; F Kawano; M Niimi; K Tobinai; T Hotta; M Shimoyama
Journal:  Br J Haematol       Date:  2001-05       Impact factor: 6.998

8.  Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease.

Authors:  M Yoshida; I Miyoshi; Y Hinuma
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

9.  Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma.

Authors:  Masahiro Kami; Tamae Hamaki; Shigesaburo Miyakoshi; Naoko Murashige; Yoshinobu Kanda; Ryuji Tanosaki; Yoichi Takaue; Shuichi Taniguchi; Hisamaru Hirai; Keiya Ozawa; Masaharu Kasai
Journal:  Br J Haematol       Date:  2003-01       Impact factor: 6.998

10.  An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support.

Authors:  H Taguchi; K I Kinoshita; K Takatsuki; M Tomonaga; K Araki; N Arima; S Ikeda; K Uozumi; H Kohno; F Kawano; H Kikuchi; H Takahashi; K Tamura; S Chiyoda; H Tsuda; H Nishimura; T Hosokawa; H Matsuzaki; S Momita; O Yamada; I Miyoshi
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-06-01
View more
  4 in total

1.  Adult T-cell leukemia cell-induced uveitis: rapid increase in adult T-cell leukemia cells disrupts the blood-ocular barrier.

Authors:  Mitsuhito Hirano; Nobuhiro Ohno; Ryuji Tanosaki; Manabu Mochizuki; Kyoko Ohno-Matsui; Kaoru Uchimaru; Arinobu Tojo; Koju Kamoi
Journal:  Int J Hematol       Date:  2017-07-04       Impact factor: 2.490

Review 2.  Current status of HTLV-1 infection.

Authors:  Toshiki Watanabe
Journal:  Int J Hematol       Date:  2011-10-04       Impact factor: 2.319

Review 3.  [Research progress on etiologic diagnosis of ocular viral diseases].

Authors:  Runping Duan; Yesheng Xu; Libin Zheng; Yufeng Yao
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2020-10-25

4.  HTLV-1 uveitis.

Authors:  Koju Kamoi; Manabu Mochizuki
Journal:  Front Microbiol       Date:  2012-07-24       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.